The Connecticut Hospice Inc. Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2017
NCT03233633
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

The Connecticut Hospice Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

cannabis (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Marijuana Abuse (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1